Dataset from A Phase III, Randomized, Double-blind, Multi-center, Placebo-controlled, Parallel-Group, Safety and Efficacy Study of SPD465 in Adults With Attention-Deficit Hyperactivity Disorder (ADHD).
收藏NIAID Data Ecosystem2026-05-10 收录
下载链接：
https://doi.org/10.25934/00007390
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to assess the safety and effectiveness of SPD465 compared to
placebo (a capsule with no medication in it) in the treatment of ADHD. The study will also
look at how SPD465 affects the participants sleep and how they perceive their quality of
life.
创建时间：
2026-03-25
